Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TMS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,271
Award facts
- Contract value 100% obligated
- $54,271.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $54.3K to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors. The contract, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a firm fixed-price transaction with no set-aside designation, indicating full and open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a ceiling value of $999.9M through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen, now operating under its parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal agencies with particular emphasis on military and veteran healthcare systems. The company's contract portfolio demonstrates extensive experience delivering brand-name and generic pharmaceuticals, vaccines, and specialized medical devices across multiple therapeutic domains. This delivery order for Dupixent, a biologic medication used to treat conditions such as atopic dermatitis and asthma, aligns with the company's established role as a prime vendor supporting the Defense Health Agency and broader Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F3TMS?
SPE2DR26F3TMS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3TMS worth?
The government has obligated $54,271 on SPE2DR26F3TMS.
Is contract SPE2DR26F3TMS an order under another contract?
Yes. SPE2DR26F3TMS is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TMS competed?
The extent of competition for SPE2DR26F3TMS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award